PC3I News
A $2.5 million gift from the Bristol Myers Squibb foundation will help establish a Geriatric Oncology Program to improve care for older adults with cancer at the Penn Medicine Princeton Cancer Center. The program will be led by PC3I Faculty Ramy Sedhom, MD.
According to Princeton Health CEO James Demetriades, approximately 70% of the center’s patients with cancer are ages 65 years or older, and these patients’ care needs often vary due to differences in social, cultural, spiritual, emotional, and financial factors. The new Geriatric Oncology Program will take a holistic approach to supportive care, and focus on designing personalized cancer care plans for patients 65 years or older. Sedhom, who is also a co-leader of the Penn Medicine Geriatric Oncology service line, will oversee the center and help expand geriatric competencies of Princeton Health staff through education and increasing outreach to seniors in the community.
The program hopes to continue helping patients like Mimi Reed, who was diagnosed with cancer at age 87 and treated with her individual goals and preferences taken into consideration. Thanks to the Geriatric Oncology program at Princeton, she was able to maintain her independence and have ongoing discussions with doctors like Sedhom about her treatment.
In an interview with Penn Medicine, Reed shared, “Dr. Sedhom is always so kind. He is an excellent listener, and from the beginning he had exceptional interest in what was on my mind.”
18 months after her diagnosis, Reed is now cancer-free and grateful for the attentive care she received at Penn’s Princeton Medical Center.
For more information, read the full press release.
Related News
PC3I News
PC3I Faculty Roger Kim Receives K08 Career Development Award from National Cancer Institute
09.21.2023
PC3I Faculty Roger Kim, MD, MSCE has been awarded a K08 Mentored Clinical Scientist Career Development Award from the National Cancer Institute, which provides support and mentorship to clinician scientists for research and career development activities.
PC3I News
Penn Center for Cancer Care Innovation 2022-2023 Impact Report
09.11.2023
PC3I is pleased to share our 2022-2023 Impact Report, which shares highlights from our work over the past year to create, test, and scale solutions to some of the most intractable problems in cancer care delivery.
PC3I News
Administrative Payment Tasks Increase Likelihood of Treatment Delays and Nonadherence
08.30.2023
A study led by PC3I Faculty Meredith Doherty, PhD, LCSW showed that patients with cancer and survivors of cancer who engaged in administrative payment tasks were more likely to experience treatment delays or treatment nonadherence.